Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Trends Cell Biol ; 28(8): 631-645, 2018 08.
Artigo em Inglês | MEDLINE | ID: mdl-29706534

RESUMO

Recent structural and functional studies of the synaptic vesicle fusion machinery suggest an inhibited tripartite complex consisting of neuronal soluble N-ethylmaleimide sensitive factor attachment protein receptors (SNAREs), synaptotagmin, and complexin prior to Ca2+-triggered synaptic vesicle fusion. We speculate that Ca2+-triggered fusion commences with the release of inhibition by Ca2+ binding to synaptotagmin C2 domains. Subsequently, fusion is assisted by SNARE complex zippering and by active membrane remodeling properties of synaptotagmin. This additional, inhibitory role of synaptotagmin may be a general principle since other recent studies suggest that Ca2+ binding to extended synaptotagmin C2 domains enables lipid transport by releasing an inhibited state of the system, and that Munc13 may nominally be in an inhibited state, which is released upon Ca2+ binding to one of its C2 domains.


Assuntos
Cálcio/farmacologia , Vesículas Sinápticas/efeitos dos fármacos , Vesículas Sinápticas/metabolismo , Animais , Sítios de Ligação/efeitos dos fármacos , Domínios C2/efeitos dos fármacos , Cálcio/metabolismo , Humanos , Proteínas SNARE/antagonistas & inibidores , Proteínas SNARE/metabolismo , Sinaptotagmina I/antagonistas & inibidores , Sinaptotagmina I/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA